Skip to content
OpenCapital
Get started

Revelation Biosciences, Inc. REVB Q4 2024 Annual earnings

Reported March 6, 2025 · Before market open

Revenue$27.0K
EPS-$14.94Miss by $5.34
EPS estimate-$9.60

Next report

Aug 7, 2026 (In 1 week)
EPS estimate-$0.83

Versus estimates

Revenue

Q4 2024$27.0K

Diluted EPS

Q1 2026-$2.71Miss by $1.56Q4 2025-$1.65Beat by $2.01Q3 2025-$7.08Miss by $1.72Q2 2025-$7.01Miss by $2.55Q1 2025-$6.33Beat by $14.31
Q4 2024-$14.94Miss by $5.34

Ask the moment Revelation Biosciences, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Revelation Biosciences, Inc. report Q4 2024 earnings?
Revelation Biosciences, Inc. (REVB) reported Q4 2024 earnings on March 6, 2025 before market open.
What were Revelation Biosciences, Inc.'s Q4 2024 revenue and EPS?
Revelation Biosciences, Inc. reported revenue of $27.0K and eps of $-14.94 for Q4 2024.
Did Revelation Biosciences, Inc. beat estimates in Q4 2024?
EPS missed the consensus estimate of $-9.60 by $5.34.
Where can I find Revelation Biosciences, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0000950170-25-034584) directly on SEC EDGAR. The filing index links above go to sec.gov.